PHARMACEUTICAL SECTOR TO PROSPER FROM INDO-SOUTH KOREA TRADE DEAL
September 1st, 2009
BY KEITH NUTHALL
THE PHARMACEUTICAL sector should prosper from a comprehensive new India and South Korea trade deal. It reduces import duties on a wide range of medicine exports from both countries. A regards India, it has promised to phase out its pharmaceutical import duties over seven years for penicillin, antibiotics, insulin, hormones, vitamins, antifungals, antihistamines, anticancer, TB, hypertension and many other medicines. South Korea, by contrast, is prepared in some instances to remove duties using a swifter schedule, for instance immediately upon ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.